Location
Central, Hong Kong
Signature
/s/ Loo See Yuen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857):

Company Role Class Num Shares Value Price $ Report Date Ownership
IGC Pharma, Inc. 10%+ Owner COMMON STOCK 13,823,529 $4,700,000 $0.3400 22 Mar 2024 Direct

Insider Reports Filed by Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857)

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IGC IGC Pharma, Inc. 22 Mar 2024 1 +$3,000,000 4 10%+ Owner 13 May 2024, 21:54
IGC IGC Pharma, Inc. 30 Jun 2023 0 $0 3 Investor 13 May 2024, 21:53